Literature DB >> 3390096

Effects of scopolamine and dextroamphetamine on human performance.

J F Schmedtje1, C M Oman, R Letz, E L Baker.   

Abstract

The effects of two drugs used to prevent symptoms of motion sickness in the operational environment were examined in this study of human performance as measured by computer-based tests of cognitive and psychomotor skills. Each subject was exposed repetitively to five tests: Symbol-Digit Substitution, Simple Reaction Time, Pattern Recognition, Digit Span Memory, and Pattern Memory. Although there have been previous reports of decreases in human performance in similar testing with higher dosages of scopolamine or dextroamphetamine, no significant decrements were observed with the operational-level combined dose used in this study (0.4 mg oral scopolamine and 5.0 mg oral dextroamphetamine.) The controversy over the use of combination drug therapy in this environment is discussed along with the indications for further research based on the findings.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3390096

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  5 in total

1.  Visually-induced tilt during parabolic flights.

Authors:  B S Cheung; I P Howard; K E Money
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

Review 2.  Cognition enhancers in age-related cognitive decline.

Authors:  W J Riedel; J Jolles
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

Review 3.  Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals.

Authors:  M Elizabeth Smith; Martha J Farah
Journal:  Psychol Bull       Date:  2011-09       Impact factor: 17.737

4.  Working memory capacity predicts effects of methylphenidate on reversal learning.

Authors:  Marieke E van der Schaaf; Sean J Fallon; Niels Ter Huurne; Jan Buitelaar; Roshan Cools
Journal:  Neuropsychopharmacology       Date:  2013-04-23       Impact factor: 7.853

5.  Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effects.

Authors:  Shaheen E Lakhan; Annette Kirchgessner
Journal:  Brain Behav       Date:  2012-07-23       Impact factor: 2.708

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.